Healthscope issues US$300M private placement notes

Company News

Healthscope Limited (ASX:HSO) has announced the successful pricing of a new US$300 million private placement note issuance to US debt investors.
 
Healthscope said the proceeds will be used to replace a tranche of the company’s existing debt facility and provide additional funding flexibility.
 
The hospital operator said the USPP notes will further improve Healthscope’s debt maturity profile and diversity of funding sources.
 
The US dollar proceeds from the USPP notes will be swapped into AUD, resulting in total funding of approximately $400 million.
 
Healthscope recorded a net profit of $95.87 million at 31st December 2015.

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.